Analystreport

AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.

AcelRx Pharmaceuticals, Inc.  (ACRX) 
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am Check Earnings Report
US:NASDAQ Investor Relations: ir.acelrx.com/investor-relations